SBIR-STTR Award

A Bioinformatics System for GCxGC-MS (Comprehensive Two-Dimensional Gas Chromography)
Award last edited on: 5/13/2005

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$593,692
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Stephen E Reichenbach

Company Information

GC Image LLC (AKA: GC Image ~ GC Imaging)

201 North 8th Street Suite 420
Lincoln, NE 68508
   (402) 310-4503
   info@gcimage.com
   www.gcimage.com
Location: Single
Congr. District: 01
County: Lancaster

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2003
Phase I Amount
$100,000
This Small Business Innovation Research (SBIR) Phase I project proposes to develop a bioinformatics system for analyzing data from comprehensive two-dimensional gas chromatography with mass spectrometry (GCxGC-MS). Comprehensive two-dimensional gas chromatography (GCxGC) is an emerging technology that provides a multiplicative increase in separation capacity over traditional GC. Mass spectrometry (MS) is a promising tool for computer- assisted and automated analyses of the incredibly complex GCxGC separations, but there is no bioinformatics software designed for working with the data generated by GCxGC-MS. The Phase I project will undertake both experimental and theoretical investigations of graphical user-interfaces for GCxGC-MS data; methods for on-line handling of large GCxGC-MS data-sets ; a language for manipulating GCxGC-MS data ; and schemes for structuring GCxGC-MS data and metadata. A prototype system will demonstrate the significance of GCxGC-MS data analyses for identifying toxic chemicals in complex environmental and health-care assays. The commercial application of this project is in the area of scientific software for GC x GC-MS. Commercial applications of GC include analyses of petroleum and chemical processing, environmental samples, foods and beverages, fragrances, health-related tests, pharmaceuticals, and toxins (including chemical warfare agents). The availability of software for computer-assisted and automated recognition of chemical components from GCxGC-MS data will facilitate adoption of GCxGC technology in laboratories using traditional GC and will contribute to the development of new markets which require superior separation performance

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2004
Phase II Amount
$493,692
This Small Business Innovation Research (SBIR) Phase II project proposes to use bioinformatics to transform complex data produced by comprehensive two-dimensional gas chromatography with mass spectrometry (GCxGC-MS) to usable chemical information. GCxGC-MS is an emerging technology for chemical separations that provides an order-of-magnitude increase in separation capacity over traditional GC. Results from Phase I demonstrated the feasibility of using bioinformatics to automatically identify chemical components in complex matrices analyzed by GCxGC-MS. Phase II will carry out further theoretical and experimental research to develop solutions that will enable broader use of GCxGC-MS system. The key project objectives include (a) developing a hybrid method that combines three approaches for chemical identification from GCxGC-MS data, (b) establishing the mathematical foundation and practical algorithms for co-elution analysis in GCxGC-MS, and (3) developing new XML technologies for shared and distributed GCxGC-MS data, metadata, and information. The commercial impact of this project will be to develop information technologies for a new generation of analytical instruments. GCxGC-MS system is likely to capture a significant share of the existing gas chromatography market, currently in excess of $ 1 billion per year, and to open new markets in applications requiring superior separations. These applications with important societal benefits, would include environmental monitoring of air, water, and soil; development and processing of foods, flavors, fragrances, and essential oils; processing of petroleum and industrial chemicals; health-care assays of blood, urine, milk, and breath samples; and analysis and discovery of drugs and medicinal herbs